NYSEMKT: ZONEZone Frontier Inc Stock
$0.10-0.02 (-16.67%)
Updated Oct 16, 2026
ZONE Price
$0.10
Fair Value Price
N/A
Market Cap
$48.34M
52 Week Low
$0.09
52 Week High
$1.31
P/E
-0.09x
P/B
0.94x
P/S
40.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.41M
Earnings
-$174.16M
Gross Margin
37.8%
Operating Margin
-5,116.82%
Profit Margin
-5,112.7%
Debt to Equity
0.02
Operating Cash Flow
-$18M
Beta
1.19
Next Earnings
Nov 12, 2026
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ZONE's potential to beat the market
- ZONE doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Pollution & Treatment Control
Industry Rating
D
ZONE
RankedUnranked of 10
RankedUnranked of 10
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $44.73 | B | |
| $104.06 | C | |
| $46.46 | C |
Be the first to know about important ZONE news, forecast changes, insider trades & much more!
ZONE News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZONE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZONE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZONE is good value based on its book value relative to its share price (0.94x), compared to the US Pollution & Treatment Controls industry average (5.17x)
P/B vs Industry Valuation
ZONE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ZONE due diligence checks available for Premium users.
Valuation
ZONE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.09x
Industry
17.12x
Market
47.98x
ZONE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.94x
Industry
5.17x
ZONE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZONE's financial health
Profit margin
Revenue
$885.9k
Net Income
-$19.2M
Profit Margin
-2,163.7%
ZONE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ZONE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$52.5M
Liabilities
$994.8k
Debt to equity
0.02
ZONE's short-term assets ($18.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZONE's short-term assets ($18.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZONE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.3M
Investing
$3.1k
Financing
$1.7M
ZONE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ZONE vs Pollution & Treatment Control Stocks
Zone Frontier Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.